BMC Medical Co., Ltd. (SHE:301367)
China flag China · Delayed Price · Currency is CNY
46.64
+0.08 (0.17%)
At close: Sep 30, 2026

BMC Medical Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
1,3771,158842.241,1191,413661.08
Other Revenue
1.211.361.243.012.621.42
1,3791,159843.481,1221,415662.5
Revenue Growth
37.15%37.46%-24.85%-20.70%113.64%18.20%
Cost of Revenue
646.18555.87449.31619.28828.15377.5
Gross Profit
732.39603.55394.17503.14587.22285
Selling, General & Admin
337.87256.16172.58142.35131.6895.52
Research & Development
143.27139.12124.62116.9872.8648.28
Other Operating Expenses
-24.59-17.43-2.76-23.5-19.3-9.51
Operating Expenses
459.18380.25297.2238.62189.01134.53
Operating Income
273.21223.3196.98264.51398.2150.47
Interest Expense
-2.34-4.97-2.85-1.36-0.46-0.2
Interest & Investment Income
50.5557.6162.3663.3620.0911.56
Currency Exchange Gain (Loss)
-39.53-10.974.51-0.411.98-3.67
Other Non Operating Income (Expenses)
-0.13-1.11-0.850.2-0.26-0.53
EBT Excluding Unusual Items
281.76263.87160.14326.31429.55157.64
Gain (Loss) on Sale of Investments
-27.39-7.8210.44---
Gain (Loss) on Sale of Assets
0.230.260.190.480.02-
Asset Writedown
-0.83-0.83-3.06-0.02--0.01
Other Unusual Items
13.635.898.427.275.526.24
Pretax Income
267.4261.36176.14334.03435.09163.86
Income Tax Expense
39.7530.117.5434.254.0618.18
Earnings From Continuing Operations
227.65231.26158.6299.83381.03145.68
Minority Interest in Earnings
-6.77-5.6-3.22-2.49-0.74-
Net Income
220.89225.66155.38297.34380.3145.68
Net Income to Common
220.89225.66155.38297.34380.3145.68
Net Income Growth
13.65%45.23%-47.74%-21.81%161.05%-36.07%
Shares Outstanding (Basic)
1241241251259994
Shares Outstanding (Diluted)
1241241251259994
Shares Change
0.22%-0.51%-0.29%26.33%5.67%-0.16%
EPS (Basic)
1.771.811.242.373.831.55
EPS (Diluted)
1.771.811.242.373.831.55
EPS Growth
13.40%45.97%-47.59%-38.11%147.04%-35.96%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
133.3197.94138.16126.98351.4694.38
Free Cash Flow Per Share
1.070.791.101.013.541.00
Dividend Per Share
0.4710.4710.2860.5101.020-
Dividend Growth
65.00%65.00%-44.00%-50.00%233.35%-
Gross Margin
53.13%52.06%46.73%44.83%41.49%43.02%
Operating Margin
19.82%19.26%11.50%23.57%28.13%22.71%
Profit Margin
16.02%19.46%18.42%26.49%26.87%21.99%
Free Cash Flow Margin
9.67%8.45%16.38%11.31%24.83%14.24%
EBITDA
285.33234.68109.53274.46403.85155.09
EBITDA Margin
20.70%20.24%12.98%24.45%28.53%23.41%
D&A For EBITDA
12.1211.3812.559.955.654.62
EBIT
273.21223.3196.98264.51398.2150.47
EBIT Margin
19.82%19.26%11.50%23.57%28.13%22.71%
Effective Tax Rate
14.87%11.52%9.96%10.24%12.42%11.09%
Revenue as Reported
1,3791,159843.481,1221,415662.5
Advertising Expenses
---39.676.744.26